Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Polomar Health Services (PMHS) EPS (Weighted Average and Diluted) (2023 - 2025)

Polomar Health Services has reported EPS (Weighted Average and Diluted) over the past 3 years, most recently at -$0.02 for Q3 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.02 for Q3 2025, down 100.0% from a year ago — trailing twelve months through Sep 2025 was -$0.09 (down 125.0% YoY), and the annual figure for FY2024 was -$0.05, down 150.0%.
  • EPS (Weighted Average and Diluted) for Q3 2025 was -$0.02 at Polomar Health Services, roughly flat from -$0.02 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for PMHS hit a ceiling of -$0.0 in Q1 2023 and a floor of -$0.03 in Q4 2024.
  • Median EPS (Weighted Average and Diluted) over the past 3 years was -$0.01 (2023), compared with a mean of -$0.01.
  • Peak annual rise in EPS (Weighted Average and Diluted) hit 0.0% in 2024, while the deepest fall reached 1150.0% in 2024.
  • Polomar Health Services' EPS (Weighted Average and Diluted) stood at -$0.01 in 2023, then tumbled by 200.0% to -$0.03 in 2024, then surged by 33.33% to -$0.02 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.02 (Q3 2025), -$0.02 (Q2 2025), and -$0.02 (Q1 2025) per Business Quant data.